Q9NS18 (GLRX2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 109.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Glutaredoxin-2, mitochondrial | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 164 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Glutathione-dependent oxidoreductase that facilitates the maintenance of mitochondrial redox homeostasis upon induction of apoptosis by oxidative stress. Involved in response to hydrogen peroxide and regulation of apoptosis caused by oxidative stress. Acts as a very efficient catalyst of monothiol reactions because of its high affinity for protein glutathione-mixed disulfides. Can receive electrons not only from glutathione (GSH), but also from thioredoxin reductase supporting both monothiol and dithiol reactions. Efficiently catalyzes both glutathionylation and deglutathionylation of mitochondrial complex I, which in turn regulates the superoxide production by the complex. Overexpression decreases the susceptibility to apoptosis and prevents loss of cardiolipin and cytochrome c release. Ref.1 Ref.9 Ref.10 Ref.11 |
| Enzyme regulation | The 2Fe-2S present in the homodimer leads to inactivation of the enzyme. The 2Fe-2S may serve as a redox sensor: the presence of one-electron oxidants or reductants leading to the loss of the 2Fe-2S cluster, subsequent monomerization and activation of the enzyme. Unlike other glutaredoxins, it is not inhibited by oxidation of structural Cys residues. Ref.12 |
| Subunit structure | Monomer; active form. Homodimer; inactive form. The homodimer is probably linked by 1 2Fe-2S cluster. Ref.12 |
| Subcellular location | Isoform 1: Mitochondrion Ref.1. |
| Tissue specificity | Widely expressed. Expressed in brain, heart, skeletal muscle, colon, thymus, spleen, kidney, liver, small intestine, placenta and lung. Not expressed in peripheral blood leukocytes. Ref.1 Ref.7 Ref.8 |
| Miscellaneous | The absence of GLRX2 dramatically sensitizes cells to cell death induced by doxorubicin/adriamycin and phenylarsine oxide. |
| Sequence similarities | Belongs to the glutaredoxin family. Contains 1 glutaredoxin domain. |
| Biophysicochemical properties | Kinetic parameters: KM=5.9 mM for GSH Ref.9 KM=0.77 mM for glutathionylated ribonuclease A KM=4.3 mM for glutathionylated BSA KM=0.11 mM for glutathionylated beta-mercaptoethanol |
| Sequence caution | The sequence AAD34128.1 differs from that shown. Reason: Frameshift at several positions. The sequence AAH28113.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NS18-1) Also known as: Grx2a; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NS18-2) Also known as: Grx2b; The sequence of this isoform differs from the canonical sequence as follows: 1-40: MIWRRAALAG...AGAAAAAASG → MNPRDKQVSR...PGRTRSAARR |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transit peptide | 1 – 19 | 19 | Mitochondrion Potential | ||||||||||||||||||||||||||
| Chain | 20 – 164 | 145 | Glutaredoxin-2, mitochondrial | PRO_0000011628 | |||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||
| Domain | 57 – 157 | 101 | Glutaredoxin | ||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||
| Metal binding | 68 | 1 | Iron-sulfur (2Fe-2S); shared with dimeric partner; in inactive form Probable | ||||||||||||||||||||||||||
| Metal binding | 153 | 1 | Iron-sulfur (2Fe-2S); shared with dimeric partner; in inactive form Probable | ||||||||||||||||||||||||||
| Binding site | 74 | 1 | Glutathione | ||||||||||||||||||||||||||
| Binding site | 109 | 1 | Glutathione | ||||||||||||||||||||||||||
| Binding site | 121 | 1 | Glutathione; via amide nitrogen and carbonyl oxygen | ||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||
| Modified residue | 77 | 1 | S-glutathionyl cysteine; alternate | ||||||||||||||||||||||||||
| Disulfide bond | 77 ↔ 80 | Redox-active; alternate By similarity | |||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||
| Alternative sequence | 1 – 40 | 40 | MIWRR…AAASG → MNPRDKQVSRFSPLKDVYTW VALAGIQRSGSPGRTRSAAR R in isoform 2. | VSP_015221 | |||||||||||||||||||||||||
| Natural variant | 95 | 1 | K → E. Ref.3 Corresponds to variant rs34237236 [ dbSNP | Ensembl ]. | VAR_025234 | |||||||||||||||||||||||||
| Isoform 2: | |||||||||||||||||||||||||||||
| Natural variant | 40 | 1 | R → W. | ||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||
| Mutagenesis | 68 | 1 | C → S: Abolishes absorption at 320 nm and 420 nm suggesting the loss of 2Fe-2S-binding. Ref.12 | ||||||||||||||||||||||||||
| Mutagenesis | 78 | 1 | S → P: Specifically increases the specific activity but decreases affinity for glutathionylated substrates. Ref.9 | ||||||||||||||||||||||||||
| Mutagenesis | 80 | 1 | C → S: Strongly impairs enzymatic activity. Ref.9 | ||||||||||||||||||||||||||
| Mutagenesis | 153 | 1 | C → S: Abolishes absorption at 320 nm and 420 nm suggesting the loss of 2Fe-2S-binding. Ref.12 | ||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||
| Helix | 57 – 66 | 10 | |||||||||||||||||||||||||||
| Beta strand | 68 – 73 | 6 | |||||||||||||||||||||||||||
| Helix | 78 – 90 | 13 | |||||||||||||||||||||||||||
| Beta strand | 95 – 98 | 4 | |||||||||||||||||||||||||||
| Helix | 99 – 101 | 3 | |||||||||||||||||||||||||||
| Helix | 105 – 116 | 12 | |||||||||||||||||||||||||||
| Beta strand | 123 – 126 | 4 | |||||||||||||||||||||||||||
| Beta strand | 129 – 133 | 5 | |||||||||||||||||||||||||||
| Helix | 134 – 142 | 9 | |||||||||||||||||||||||||||
| Helix | 146 – 152 | 7 | |||||||||||||||||||||||||||
| Beta strand | 154 – 156 | 3 | |||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms." Lundberg M., Johansson C., Chandra J., Enoksson M., Jacobsson G., Ljung J., Johansson M., Holmgren A. J. Biol. Chem. 276:26269-26275(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Colon and Testis. |
| [2] | "Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2." Gladyshev V.N., Liu A., Novoselov S.V., Krysan K., Sun Q.-A., Kryukov V.M., Kryukov G.V., Lou M.F. J. Biol. Chem. 276:30374-30380(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [3] | NIEHS SNPs program Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT GLU-95. |
| [4] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics." Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C. Genome Res. 10:703-713(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-164 (ISOFORM 1). |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-164 (ISOFORM 1). Tissue: Mammary gland. |
| [7] | "Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems." Lundberg M., Fernandes A.P., Kumar S., Holmgren A. Biochem. Biophys. Res. Commun. 319:801-809(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [8] | "Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo." Peltoniemi M., Kaarteenaho-Wiik R., Saily M., Sormunen R., Paakko P., Holmgren A., Soini Y., Kinnula V.L. Hum. Pathol. 35:1000-1007(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [9] | "Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase." Johansson C., Lillig C.H., Holmgren A. J. Biol. Chem. 279:7537-7543(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF SER-78 AND CYS-80. |
| [10] | "Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide." Lillig C.H., Loenn M.E., Enoksson M., Fernandes A.P., Holmgren A. Proc. Natl. Acad. Sci. U.S.A. 101:13227-13232(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [11] | "Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release." Enoksson M., Fernandes A.P., Prast S., Lillig C.H., Holmgren A., Orrenius S. Biochem. Biophys. Res. Commun. 327:774-779(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [12] | "Characterization of human glutaredoxin 2 as iron-sulfur protein: a possible role as redox sensor." Lillig C.H., Berndt C., Vergnolle O., Loenn M.E., Hudemann C., Bill E., Holmgren A. Proc. Natl. Acad. Sci. U.S.A. 102:8168-8173(2005) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT, ENZYME REGULATION, METAL-BINDING, MUTAGENESIS OF CYS-68 AND CYS-153. |
| [13] | "Solution structure of RSGI RUH-044, an N-terminal 2 domain of glutaredoxin 2 from human cDNA." RIKEN structural genomics initiative (RSGI) Submitted (NOV-2005) to the PDB data bank Cited for: STRUCTURE BY NMR OF 48-164. |
| [14] | "Reversible sequestration of active site cysteines in a 2Fe-2S-bridged dimer provides a mechanism for glutaredoxin 2 regulation in human mitochondria." Johansson C., Kavanagh K.L., Gileadi O., Oppermann U. J. Biol. Chem. 282:3077-3082(2007) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 50-164 IN COMPLEX WITH GLUTATHIONE. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF132495 mRNA. Translation: AAF37320.2. AF290514 mRNA. Translation: AAK83089.1. AY038988 mRNA. Translation: AAK72499.1. DQ194815 Genomic DNA. Translation: ABA03170.1. AL136370 Genomic DNA. Translation: CAI10820.1. AL136370 Genomic DNA. Translation: CAI10821.1. AF151891 mRNA. Translation: AAD34128.1. Frameshift. BC028113 mRNA. Translation: AAH28113.1. Different initiation. | ||||||||||||||||||||||||
| IPI | IPI00007045. IPI00100044. | ||||||||||||||||||||||||
| RefSeq | NP_001230328.1. NM_001243399.1. NP_057150.2. NM_016066.4. NP_932066.1. NM_197962.2. | ||||||||||||||||||||||||
| UniGene | Hs.458283. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | Q9NS18. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| STRING | 9606.ENSP00000356410. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q9NS18. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 73919686. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | Q9NS18. | ||||||||||||||||||||||||
| PRIDE | Q9NS18. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000367439; ENSP00000356409; ENSG00000023572. ENST00000367440; ENSP00000356410; ENSG00000023572. | ||||||||||||||||||||||||
| GeneID | 51022. | ||||||||||||||||||||||||
| KEGG | hsa:51022. | ||||||||||||||||||||||||
| UCSC | uc001gsz.2. human. uc001gta.2. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 51022. | ||||||||||||||||||||||||
| GeneCards | GC01M193065. | ||||||||||||||||||||||||
| HGNC | HGNC:16065. GLRX2. | ||||||||||||||||||||||||
| HPA | HPA023087. | ||||||||||||||||||||||||
| MIM | 606820. gene. | ||||||||||||||||||||||||
| neXtProt | NX_Q9NS18. | ||||||||||||||||||||||||
| PharmGKB | PA28732. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | COG0695. | ||||||||||||||||||||||||
| HOGENOM | HOG000095204. | ||||||||||||||||||||||||
| HOVERGEN | HBG096801. | ||||||||||||||||||||||||
| KO | K03676. | ||||||||||||||||||||||||
| OMA | AGTRLVW. | ||||||||||||||||||||||||
| OrthoDB | EOG498V20. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| SABIO-RK | Q9NS18. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| Bgee | Q9NS18. | ||||||||||||||||||||||||
| CleanEx | HS_GLRX2. | ||||||||||||||||||||||||
| Genevestigator | Q9NS18. | ||||||||||||||||||||||||
| GermOnline | ENSG00000023572. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 3.40.30.10. 1 hit. | ||||||||||||||||||||||||
| InterPro | IPR002109. Glutaredoxin. IPR011899. Glutaredoxin_euk/vir. IPR014025. Glutaredoxin_subgr. IPR015450. Grx-2. IPR012336. Thioredoxin-like_fold. [Graphical view] | ||||||||||||||||||||||||
| PANTHER | PTHR10168:SF17. PTHR10168:SF17. 1 hit. | ||||||||||||||||||||||||
| Pfam | PF00462. Glutaredoxin. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00160. GLUTAREDOXIN. | ||||||||||||||||||||||||
| SUPFAM | SSF52833. Thiordxn-like_fd. 1 hit. | ||||||||||||||||||||||||
| TIGRFAMs | TIGR02180. GRX_euk. 1 hit. | ||||||||||||||||||||||||
| PROSITE | PS00195. GLUTAREDOXIN_1. False negative. PS51354. GLUTAREDOXIN_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| DrugBank | DB00143. Glutathione. | ||||||||||||||||||||||||
| EvolutionaryTrace | Q9NS18. | ||||||||||||||||||||||||
| GenomeRNAi | 51022. | ||||||||||||||||||||||||
| NextBio | 53548. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | GLRX2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NS18 Secondary accession number(s): Q3LR69 Q9Y3D4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
